# NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B

> Pre-procurement notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS ENGLAND](/buyers/nhs-england/contract-awards)
- Tender value: £250,000,000
- Published: 15 December 2021
- Planned start: 1 July 2022
- Planned end: 30 June 2024
- Stage: pre_procurement
- Notice ID: 58917ecb-2584-47aa-b8eb-63f97412452d-494393
- OCID: ocds-b5fd17-1e814412-b1d6-4783-86c3-93247e9d3ac0

## Description

National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\. Total maximum framework agreement including extension options will be no more than 48 months

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/58917ecb-2584-47aa-b8eb-63f97412452d-494393)